Anne Cambon‐Thomsen

Centre National de la Recherche Scientifique — France

Immunology and Microbiology · Life Sciences

51h-index13.8kcitations365works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(57), Ethics in Clinical Research(52), Cancer Genomics and Diagnostics(50), Biomedical Ethics and Regulation(41), Renal cell carcinoma treatment(36)

Publications363 total

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study
EClinicalMedicine·2025Open Access
Supplementary Methods S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Table S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Tables S3-S13 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S3 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Table S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Genomic Medicine and Equity in Relation to Health Systems
The American Journal of Bioethics·2025
Emerging and evolving values in the changing landscape of genomics
Frontiers in Genetics·2025· 3 citedOpen Access
Recommendations on Open Science Rewards and Incentives
Data Science Journal·2025· 1 citedOpen Access
Gaps between Open Science activities and actual recognition systems: Insights from an international survey
PLoS ONE·2024· 3 citedOpen Access
Bioethics “Laws”: Paradox or Way of the Future?
2024Open Access
Gaps between Open Science activities and actual recognition systems: Insights from an international survey
2024· 2 citedOpen Access
Ethical and social implications of public–private partnerships in the context of genomic/big health data collection
European Journal of Human Genetics·2024· 7 citedOpen Access
New regulatory dimensions for transplantation, genetics and stem cell research in the French bioethics law. Consequences for European collaborations
SPIRE - Sciences Po Institutional REpository·2023
Data sharing, research evaluation and Open Science
SPIRE - Sciences Po Institutional REpository·2023
Figure S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2023Open Access
Figure S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2023Open Access
Data from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2023Open Access
page 1 of 19Next →

Frequent Co-authors

Jørn Nerup(7), Charles Auffray(7), Emmanuelle Rial‐Sebbag(6), Flemming Pociot(6), Judith García‐Aymerich(6), Martina C. Cornel(5), M. L. Kowalski(5), Jean Bousquet(5), Mübeccel Akdiş(5), Thomas Keil(5), Isabelle Momas(5), Rudolf Valenta(5), Magnus Wickman(5), Tari Haahtela(5), Bart N. Lambrecht(5), Gerard H. Koppelman(5), Jordi Sunyer(5), Torsten Zuberbier(5), Joachim Heinrich(5), John Wright(5)